"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
| Descriptor ID |
D001323
|
| MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 3 | 3 |
| 2002 | 5 | 1 | 6 |
| 2003 | 0 | 3 | 3 |
| 2004 | 3 | 3 | 6 |
| 2005 | 3 | 5 | 8 |
| 2006 | 5 | 6 | 11 |
| 2007 | 4 | 5 | 9 |
| 2008 | 6 | 2 | 8 |
| 2009 | 4 | 7 | 11 |
| 2010 | 3 | 7 | 10 |
| 2011 | 9 | 4 | 13 |
| 2012 | 4 | 5 | 9 |
| 2013 | 11 | 1 | 12 |
| 2014 | 8 | 0 | 8 |
| 2015 | 2 | 4 | 6 |
| 2016 | 6 | 6 | 12 |
| 2017 | 4 | 7 | 11 |
| 2018 | 6 | 1 | 7 |
| 2019 | 8 | 6 | 14 |
| 2020 | 6 | 3 | 9 |
| 2021 | 5 | 10 | 15 |
| 2022 | 1 | 13 | 14 |
| 2023 | 0 | 16 | 16 |
| 2024 | 5 | 9 | 14 |
| 2025 | 3 | 9 | 12 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e493-e499.
-
Microbial associations and viruses on the risk of celiac disease (MAVRiC): a longitudinal post-hoc case-cohort study. Sci Rep. 2025 Nov 28; 15(1):42704.
-
Immunomodulation of behavior impairment via spleen-specific targeting lipid nanoparticles in a MeCP2 transgenic mouse model. Sci Rep. 2025 Oct 31; 15(1):38135.
-
Immune Thrombotic Thrombocytopenic Purpura: A Review. JAMA. 2025 08 12; 334(6):517-529.
-
Successful Treatment of Double-Positive Rapidly Progressive Glomerulonephritis: A Case Report. J Investig Med High Impact Case Rep. 2025 Jan-Dec; 13:23247096251365418.
-
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors. ESMO Open. 2025 Aug; 10(8):105518.
-
Development and recalibration?of a?multivariable?type 1 diabetes prediction model for?type 1 diabetes across multiple screening studies. BMC Med. 2025 Jul 21; 23(1):433.
-
Characterizing local antibody responses in the muscle of inclusion body myositis patients. J Autoimmun. 2025 Jun; 154:103437.
-
MOGAD optic neuritis after mild head/orbital trauma in six children. J Neuroimmunol. 2025 Jul 15; 404:578605.
-
Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.